|
|
|
Clinical Research Detail |
|
|
|
Title Of Study |
This is a multicenter, open-label, two-arm, Phase 2 clinical study and will be conducted in male and female subjects aged 18 years and older with advanced NSCLC who have progressed after first line therapy, to evaluate the safety and efficacy of erlotinib in combination with CS-7017.
|
|
|
Disease Condition |
Treatment of patients with advanced non-small cell lung cancer (NSCLC) after failure of a prior chemotherapy regimen.
|
|
|
Phase of Trial |
Phase-2
|
Discipline |
Oncology
|
|
|
Start date of Trial |
10/1/2010
|
Closing Date of Trial |
10/1/2011
|
|
|
|